SIGNIFOR pasireotide 300 microgram/1 mL (as diaspartate) solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 300 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 376.2 microgram (equivalent: pasireotide, qty microgram) - injection, solution - excipient ingredients: water for injections; mannitol; tartaric acid; sodium hydroxide - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

SIGNIFOR pasireotide 600 microgram/1 mL (as diaspartate) solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 600 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 752.4 microgram (equivalent: pasireotide, qty 600 microgram) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; tartaric acid; mannitol - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

SANCUSO- granisetron patch United States - English - NLM (National Library of Medicine)

sancuso- granisetron patch

kyowa kirin, inc. - granisetron (unii: wzg3j2mcol) (granisetron - unii:wzg3j2mcol) - granisetron 3.1 mg in 24 h - sancuso® is indicated for the prevention of nausea and vomiting in adults receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration. sancuso is contraindicated in patients with known hypersensitivity to granisetron or to any of the components of the transdermal system [see description (10)] . risk summary available published data and postmarketing reports with granisetron use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in a published ex vivo human placental perfusion model, no transplacental passage of granisetron was detected at a concentration (5 ng/ml) that mimics the plasma concentration achieved following transdermal application of sancuso. in animal reproduction studies, no adverse developmental effects were observed in pregnant rats and rabbits administered granisetron hydrochloride during organogenesis at intravenous doses up to 24 times and 16 times, respective

Ostiral 60mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ostiral 60mg tablets

lupin healthcare (uk) ltd - raloxifene hydrochloride - oral tablet - 60mg

Cardioroot Woven - Graft, vascular, synthetic Australia - English - Department of Health (Therapeutic Goods Administration)

cardioroot woven - graft, vascular, synthetic

getinge australia pty ltd - 35281 - graft, vascular, synthetic - made of woven polyester and coated with a highly purified form of cross-linked bovine collagen to minimize intraoperative bleeding and eliminate the need for preclotting at the time of implant. the intergard woven vascular grafts have an integral water permeability specification of < 5 ml/cm?/min at 120 mmhg. cardioroot graft features an uncrimped bulged section with a 1-cm collar at its proximal end. this design mimics the anatomy and blood flow dynamics. the intended purpose is for surgical repair, bypass or replacement of arteries in the treatment of aneurysmal and occlusive disease of the aorta, both thoracic and abdominal, visceral arteries, and proximal peripheral arteries. due to their low permeability, these products are recommended for use in patients requiring heparinization prior to, or during surgery.

XOFIGO INJECTION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

xofigo injection

bayer (pty) ltd û isando - injection - see ingredients - each 1,0 ml solution contains radium-224 0,53 ng

Colex-D Herbicide Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

colex-d herbicide

corteva agriscience australia pty ltd - 2,4-d present as the choline salt - soluble concentrate - 2,4-d present as the choline salt active 456.0 g/l - herbicide